Diagnostic Photonics Featured in Chicago Tribune

Diagnostic Photonics, a Serra Capital I and II portfolio company, was featured in the Chicago Tribune on January 7. The Chicago startup has successfully raised $3.1M to fund a clinical trial for its high-resolution imaging probes for cancer surgeons.

The new funding will contribute to a nationwide, 400-person study with the goal of gaining FDA clearance. Serra Ventures was listed in the article as an investor in the round.

Source: http://www.chicagotribune.com/bluesky/orig...

Nanomedical Diagnostics Announces Scientific Advisory Board of Top Scientists and Medical Researchers

Nanomedical Diagnostics, a Serra Capital II portfolio company, announced its scientific advisory board of leading scientists and medical researchers on December 11. Nanomedical Diagnostics is a biotech company developing and commercializing cutting-edge graphene biosensor technology for use in research and diagnostics.

The scientific advisory board provides key strategic input, technical guidance, and research expertise to the company as it prepares AGILE Research, its new graphene biosensor for small molecule and protein analysis, for commercial release early next year.

Kypha Raises $2.1 Million in Debt Offering

Kypha, a Serra Capital II company, was featured by the St. Louis Business Journal on November 13. Kypha is an early-stage company developing new products to improve the way inflammation and immune activity is monitored and treated.

Kypha has raised $2.1 million in a debt offering, according to a filing with the Securities and Exchange Commission. The article also listed Serra Ventures as an investor.


Source: http://www.bizjournals.com/stlouis/blog/bi...